Skip to main content
رجوع
Watch Compare

Vicarious Surgical Inc.

جودة البيانات: 83%
مُدرج أيضًا باسم RBOTW OTC
RBOT
OTC Manufacturing Measuring & Analyzing Instruments
KWD 0.70
▼ KWD 0.07 (-8.50%)
القيمة السوقية: 4.99 M
السعر
KWD 0.70
القيمة السوقية
4.99 M
نطاق اليوم
KWD 0.70 — KWD 0.76
نطاق 52 أسبوعًا
KWD 0.27 — KWD 13.75
حجم التداول
2,607
فتح KWD 0.76
متوسط 50 يوم / 200 يوم
KWD 1.45
51.74% below
متوسط 50 يوم / 200 يوم
KWD 4.61
84.80% below

Quick Summary

النقاط الرئيسية

Negative free cash flow of -45.21 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-270.15%
أقل من متوسط القطاع (-51.02%)
ROIC-127.56%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio4.75
Interest CoverageN/A

التقييم

PE (TTM)
-0.10
أعلى من متوسط القطاع (-1.98)
P/B Ratio0.35
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (44 نظير)
المقياس السهم وسيط القطاع
P/E -0.1 -2.0
P/B 0.4 5.1
ROE % -270.2 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -50.18 M
ROE -270.15% ROA -142.89%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -45.21 M
ROIC -127.56% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4.75
Interest Coverage N/A Asset Turnover N/A
Working Capital 11.90 M Tangible Book Value 14.09 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.10 Forward P/E N/A
P/B Ratio 0.35 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -906.53%
Market Cap 4.99 M Enterprise Value 1.82 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -6.35 OCF / Share -6.33
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 90.09%
SBC-Adj. FCF -55.18 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Revenue — — — — —
Net Income -50.18 M -63.22 M -71.07 M 5.16 M -161,178.0
EPS (Diluted) — — -0.49 0.04 —
Gross Profit — — — — —
Operating Income -50.03 M -66.56 M -80.67 M -80.08 M —
EBITDA — — — — —
R&D Expenses 33.60 M 40.16 M 47.58 M 43.90 M —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — 25,000.0 25,000.0 200,000.0 —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Total Assets 19.58 M 67.72 M 119.86 M 140.29 M 346.42 M
Total Liabilities 9.74 M 21.02 M 21.90 M 29.25 M 12.20 M
Shareholders' Equity 9.84 M 46.70 M 97.97 M 111.05 M 5.00 M
Total Debt — — 2.00 M 2.18 M —
Cash & Equivalents 2.57 M 9.74 M 52.82 M 116.21 M 1.10 M
Current Assets 11.58 M 51.70 M 100.95 M 120.40 M 1.23 M
Current Liabilities 3.90 M 7.67 M 7.28 M 8.39 M 126,220.0